Akari Therapeutics PLC financial statements
Akari Therapeutics PLC's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 17.3M | 10-K |
| Cash and equivalents | USD 5.2M | 10-Q |
| Total debt | USD 754K | EODHD |
Akari Therapeutics PLC financials on 6ix · Akari Therapeutics PLC on 6ix